Early use of corticosteroids in non-critical patients with COVID-19 pneumonia (PREDCOVID): a structured summary of a study protocol for a randomised controlled trial

OBJECTIVES: To evaluate the efficacy of early treatment with prednisone to decrease the progression of COVID-19 pneumonia. TRIAL DESIGN: This is a pragmatic, non-blinded, randomized, two arms, parallel trial. PARTICIPANTS: Patients between 18 and 90 years, with COVID-19 pneumonia, confirmed by RT PC...

Descripción completa

Detalles Bibliográficos
Autores principales: Salinas, Mauricio, Andino, Paulette, Palma, Leonor, Valencia, Javiera, Figueroa, Elizabeth, Ortega, Jhonatan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7835442/
https://www.ncbi.nlm.nih.gov/pubmed/33499887
http://dx.doi.org/10.1186/s13063-021-05046-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7835442/
https://www.ncbi.nlm.nih.gov/pubmed/33499887
http://dx.doi.org/10.1186/s13063-021-05046-6

Ejemplares similares